Rick E Winningham Jazz Pharmaceuticals PLC (JAZZ) insider trading activity

Rick E Winningham is Director of Jazz Pharmaceuticals plc. Currently has a direct ownership of 8,893 shares of JAZZ, which is worth approximately $1.25 Million. The most recent transaction as insider was on Nov 18, 2025, when has been sold 5,500 shares (Ordinary Shares) at a price of $180.86 per share, resulting in proceeds of $994,730. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 8.89K

38.21% 3M change

29.93% 12M change

Total Value Held $1.25 Million

Rick E Winningham Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Nov 18 2025	SELL Open market or private sale	$994,730 $180.86 p/Share	5,500 Reduced 38.21%	8,893 Ordinary Shares
Aug 08 2025	SELL Payment of exercise price or tax liability	$200,806 $111.25 p/Share	1,805 Reduced 11.14%	14,393 Ordinary Shares
Aug 07 2025	BUY Grant, award, or other acquisition	-	3,507 Added 17.8%	16,198 Ordinary Shares
Aug 06 2024	SELL Payment of exercise price or tax liability	$165,243 $111.35 p/Share	1,484 Reduced 10.47%	12,691 Ordinary Shares
Aug 02 2024	BUY Grant, award, or other acquisition	-	3,731 Added 20.84%	14,175 Ordinary Shares
Aug 14 2023	SELL Open market or private sale	$171,456 $138.16 p/Share	1,241 Reduced 10.62%	10,444 Ordinary Shares
Aug 11 2023	BUY Grant, award, or other acquisition	-	3,075 Added 20.83%	11,685 Ordinary Shares

Aug 08 2022	SELL Open market or private sale	$165,876 $152.32 p/Share	1,089 Reduced 11.23%	8,610 Ordinary Shares
Aug 05 2022	BUY Grant, award, or other acquisition	-	2,561 Added 20.89%	9,699 Ordinary Shares
Aug 06 2021	SELL Open market or private sale	$193,236 $147.96 p/Share	1,306 Reduced 15.47%	7,138 Ordinary Shares
Jul 29 2021	BUY Grant, award, or other acquisition	-	2,246 Added 21.01%	8,444 Ordinary Shares

Also insider at

TBPH

Theravance Biopharma, Inc. Healthcare

CHIEF EXECUTIVE OFFICER

REW